09/12/2023 3:07 PM | BOHLIN GAREN G (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 3:27 PM | Cheng Sohanya Roshan (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 3:29 PM | Karyopharm Therapeutics (Issuer) Mano Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/01/2023 7:06 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/01/2023 7:17 AM | Karyopharm Therapeutics (Issuer) Su Zhen (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/01/2023 7:20 AM | Karyopharm Therapeutics (Issuer) Su Zhen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/02/2023 7:59 AM | Karyopharm Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
08/02/2023 6:48 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/02/2023 6:37 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2023 4:37 PM | Karyopharm Therapeutics (Issuer) Poulton Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2023 1:26 PM | Karyopharm Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
07/06/2023 4:36 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2023 11:15 PM | Karyopharm Therapeutics (Filer)
| Form EFFECT | |
05/04/2023 6:53 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/04/2023 7:04 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/24/2023 5:09 PM | Karyopharm Therapeutics (Issuer) Rangwala Reshma (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2023 7:02 AM | Karyopharm Therapeutics (Filer)
| Form DEF 14A | |
04/11/2023 7:11 AM | Karyopharm Therapeutics (Filer)
| Form DEFA14A | |
04/11/2023 7:19 AM | Karyopharm Therapeutics (Filer)
| Form ARS | |
03/02/2023 4:38 PM | Karyopharm Therapeutics (Issuer) Poulton Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/02/2023 4:39 PM | Karyopharm Therapeutics (Issuer) Rangwala Reshma (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/02/2023 4:28 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/02/2023 4:30 PM | Karyopharm Therapeutics (Issuer) Mason Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/02/2023 4:33 PM | Cheng Sohanya Roshan (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/02/2023 4:35 PM | Karyopharm Therapeutics (Issuer) Mano Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/02/2023 4:36 PM | Karyopharm Therapeutics (Issuer) Mitchener Stephen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/17/2023 7:52 AM | Karyopharm Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/17/2023 7:59 AM | Karyopharm Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
02/17/2023 6:34 AM | Karyopharm Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/15/2023 6:53 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2023 2:41 PM | Chione Ltd (Filed by) Karyopharm Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2023 2:31 PM | Avidity Partners Management LP (Filed by) Karyopharm Therapeutics (Subject)
| Form SC 13G/A | |
02/02/2023 11:38 AM | Karyopharm Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/20/2023 4:17 PM | BlackRock Inc. (Filed by) Karyopharm Therapeutics (Subject)
| Form SC 13G | |
01/09/2023 7:06 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2023 5:16 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2023 11:15 PM | Karyopharm Therapeutics (Filer)
| Form EFFECT | |
12/23/2022 3:14 PM | Karyopharm Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
12/08/2022 9:22 AM | Avidity Partners Management LP (Filed by) Karyopharm Therapeutics (Subject)
| Form SC 13G | |
12/05/2022 7:41 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2022 5:19 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|